Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers

by Jana Rolff, Cornelia Dorn, Johannes Merk, Iduna Fichtner
Published 2009-01-01

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

by Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann, Cornelia Dorn, W. Dieter Paar
Published 2019-07-01

Outlier-based identification of copy number variations using targeted resequencing in a small cohort of patients with Tetralogy of Fallot.

by Vikas Bansal, Cornelia Dorn, Marcel Grunert, Sabine Klaassen, Roland Hetzer, Felix Berger, Silke R Sperling
Published 2014-01-01

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease

by Daniel Steffens, Julia Müller, Cornelia Dorn, W Dieter Paar, Celine Scheeff, Mario Kasner, U Rauch-Kröhnert
Published 2021-06-01

Muscle-relevant genes marked by stable H3K4me2/3 profiles and enriched MyoD binding during myogenic differentiation.

by Huanhuan Cui, Vikas Bansal, Marcel Grunert, Barbora Malecova, Alessandra Dall'Agnese, Lucia Latella, Sole Gatto, Tammy Ryan, Kerstin Schulz, Wei Chen, Cornelia Dorn, Pier Lorenzo Puri, Silke R Sperling
Published 2017-01-01